4//SEC Filing
aTYR PHARMA INC 4
Accession 0001209191-15-077529
$ATYRCIK 0001339970operating
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 6:07 PM ET
Size
5.5 KB
Accession
0001209191-15-077529
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Blake John T
Vice President, Finance
Transactions
- Award
Employee Stock Option (right to buy)
2015-10-28+7,500→ 7,500 totalExercise: $12.49Exp: 2025-10-28→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on November 28, 2015, such that this option will be fully exercisable on October 28, 2019. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001339970
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 6:07 PM ET
- Size
- 5.5 KB